LINC01111

Across TCGA pan-cancer cohorts, LINC01111 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC01111 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01111 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01111 expression acts as an unfavorable survival marker, although some lineages such as UCS and BLCA show a favorable association.

ACC, UCS, and LUAD are the cancer types where LINC01111 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.224	0.715	<.001	150	view →
UCS	OS	Tertile	II,III,IV	0.841	0.263	<.001	98	view →
LUAD	OS	Tertile	II,III,IV	0.335	0.575	.005	60	view →
LGG	DFS	Median	All	0.331	0.468	<.001	52	view →
MESO	OS	Quartile	IV	0.122	0.682	.005	47	view →
BLCA	OS	Tertile	All	0.628	0.385	.011	45	view →
SKCM	OS	Tertile	All	0.816	0.893	.004	42	view →
COAD	OS	Tertile	IV	0.133	0.677	<.001	36	view →
ESCA	DFS	Quartile	II,III,IV	0.360	0.568	.009	15	view →
KIRC	DFS	Median	All	0.815	0.904	.005	15	view →
SARC	OS	Quartile	All	0.341	0.672	.003	14	view →
THCA	DFS	Tertile	IV	0.676	0.935	.044	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC01111–ACC (OS)

Open the ACC breakdown →